Advertisement
| cancers are hard to study because: Analysis of Cancer Risks in Populations Near Nuclear Facilities National Research Council, Division on Earth and Life Studies, Nuclear and Radiation Studies Board, Committee on the Analysis of Cancer Risks in Populations near Nuclear Facilitiesâ¬"Phase I, 2012-06-29 In the late 1980s, the National Cancer Institute initiated an investigation of cancer risks in populations near 52 commercial nuclear power plants and 10 Department of Energy nuclear facilities (including research and nuclear weapons production facilities and one reprocessing plant) in the United States. The results of the NCI investigation were used a primary resource for communicating with the public about the cancer risks near the nuclear facilities. However, this study is now over 20 years old. The U.S. Nuclear Regulatory Commission requested that the National Academy of Sciences provide an updated assessment of cancer risks in populations near USNRC-licensed nuclear facilities that utilize or process uranium for the production of electricity. Analysis of Cancer Risks in Populations near Nuclear Facilities: Phase 1 focuses on identifying scientifically sound approaches for carrying out an assessment of cancer risks associated with living near a nuclear facility, judgments about the strengths and weaknesses of various statistical power, ability to assess potential confounding factors, possible biases, and required effort. The results from this Phase 1 study will be used to inform the design of cancer risk assessment, which will be carried out in Phase 2. This report is beneficial for the general public, communities near nuclear facilities, stakeholders, healthcare providers, policy makers, state and local officials, community leaders, and the media. |
| cancers are hard to study because: Molecular Biology of the Cell , 2002 |
| cancers are hard to study because: Cancer Care for the Whole Patient Institute of Medicine, Board on Health Care Services, Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008-03-19 Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. This failure can compromise the effectiveness of health care and thereby adversely affect the health of cancer patients. Psychological and social problems created or exacerbated by cancer-including depression and other emotional problems; lack of information or skills needed to manage the illness; lack of transportation or other resources; and disruptions in work, school, and family life-cause additional suffering, weaken adherence to prescribed treatments, and threaten patients' return to health. Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. Cancer Care for the Whole Patient recommends actions that oncology providers, health policy makers, educators, health insurers, health planners, researchers and research sponsors, and consumer advocates should undertake to ensure that this standard is met. |
| cancers are hard to study because: Assessment of Cancer Screening Pamela M. Marcus, 2022 Cancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years. |
| cancers are hard to study because: The Surgeon General's Call to Action to Prevent Skin Cancer Office of Office of the Surgeon, U.S. Department of Health and Human Services, 2019-07-27 This document is a Call to Action to partners in prevention from various sectors across the nation to address skin cancer as a major public health problem. Many partners are essential to this effort, including federal, state, tribal, local, and territorial governments; members of the business, health care, and education sectors; community, nonprofit, and faith-based organizations; and individuals and families. The goal of this document is to increase awareness of skin cancer and to call for actions to reduce its risk.The first section describes the problem of skin cancer and its major risk factors. It also discusses the relationship between exposure to ultraviolet (UV) radiation and health. The second section describes the current evidence on preventing skin cancer, including current initiatives in the United States and in other countries. The third section describes the gaps in research related to skin cancer prevention, highlighting areas of research where more work is needed. The fourth section identifies specific opportunities to prevent skin cancer by reducing UV exposure in the U.S. population and calls for nationwide action. |
| cancers are hard to study because: The Genetics of Cancer B.A. Ponder, Michael Waring, 2012-10-14 It has been recognized for almost 200 years that certain families seem to inherit cancer. It is only in the past decade, however, that molecular genetics and epidemiology have combined to define the role of inheritance in cancer more clearly, and to identify some of the genes involved. The causative genes can be tracked through cancer-prone families via genetic linkage and positional cloning. Several of the genes discovered have subsequently been proved to play critical roles in normal growth and development. There are also implications for the families themselves in terms of genetic testing with its attendant dilemmas, if it is not clear that useful action will result. The chapters in The Genetics of Cancer illustrate what has already been achieved and take a critical look at the future directions of this research and its potential clinical applications. |
| cancers are hard to study because: Cancer Control Opportunities in Low- and Middle-Income Countries Institute of Medicine, Board on Global Health, Committee on Cancer Control in Low- and Middle-Income Countries, 2007-01-26 Cancer is low or absent on the health agendas of low- and middle-income countries (LMCs) despite the fact that more people die from cancer in these countries than from AIDS and malaria combined. International health organizations, bilateral aid agencies, and major foundations—which are instrumental in setting health priorities—also have largely ignored cancer in these countries. This book identifies feasible, affordable steps for LMCs and their international partners to begin to reduce the cancer burden for current and future generations. Stemming the growth of cigarette smoking tops the list to prevent cancer and all the other major chronic diseases. Other priorities include infant vaccination against the hepatitis B virus to prevent liver cancers and vaccination to prevent cervical cancer. Developing and increasing capacity for cancer screening and treatment of highly curable cancers (including most childhood malignancies) can be accomplished using resource-level appropriateness as a guide. And there are ways to make inexpensive oral morphine available to ease the pain of the many who will still die from cancer. |
| cancers are hard to study because: Stress and Breast Cancer Cary L. Cooper, 1988 In recent years interest has increased in the links between stress and breast cancer, reflecting the growing concern at the continuing increase in the disease. This book brings together leading researchers in the field to review the evidence available. |
| cancers are hard to study because: Fulfilling the Potential of Cancer Prevention and Early Detection National Research Council, Institute of Medicine, National Cancer Policy Board, 2003-05-07 Cancer ranks second only to heart disease as a leading cause of death in the United States, making it a tremendous burden in years of life lost, patient suffering, and economic costs. Fulfilling the Potential for Cancer Prevention and Early Detection reviews the proof that we can dramatically reduce cancer rates. The National Cancer Policy Board, part of the Institute of Medicine, outlines a national strategy to realize the promise of cancer prevention and early detection, including specific and wide-ranging recommendations. Offering a wealth of information and directly addressing major controversies, the book includes: A detailed look at how significantly cancer could be reduced through lifestyle changes, evaluating approaches used to alter eating, smoking, and exercise habits. An analysis of the intuitive notion that screening for cancer leads to improved health outcomes, including a discussion of screening methods, potential risks, and current recommendations. An examination of cancer prevention and control opportunities in primary health care delivery settings, including a review of interventions aimed at improving provider performance. Reviews of professional education and training programs, research trends and opportunities, and federal programs that support cancer prevention and early detection. This in-depth volume will be of interest to policy analysts, cancer and public health specialists, health care administrators and providers, researchers, insurers, medical journalists, and patient advocates. |
| cancers are hard to study because: Identifying and Addressing the Needs of Adolescents and Young Adults with Cancer National Cancer Policy Forum, Board on Health Care Services, A LIVESTRONG and Institute of Medicine Workshop, Institute of Medicine, 2014-05-18 Identifying and Addressing the Needs of Adolescents and Young Adults with Cancer is the summary of a workshop convened by the Institute of Medicine's National Cancer Policy Forum in July 2013 to facilitate discussion about gaps and challenges in caring for adolescent and young adult cancer patients and potential strategies and actions to improve the quality of their care. The workshop featured invited presentations from clinicians and other advocates working to improve the care and outcomes for the adolescent and young adult population with cancer. Cancer is the leading disease-related cause of death in adolescents and young adults. Each year nearly 70,000 people between the ages of 15 and 39 are diagnosed with cancer, approximately 8 times more than children under age 15. This population faces a variety of unique short- and long-term health and psychosocial issues, such as difficulty reentering school, the workforce, or the dating scene; problems with infertility; cardiac, pulmonary, or other treatment repercussions; and secondary malignancies. Survivors are also at increased risk for psychiatric conditions such as anxiety, depression, substance abuse, and suicide and may have difficulty acquiring health insurance and paying for needed care. Identifying and Addressing the Needs of Adolescents and Young Adults with Cancer discusses a variety of topics important to adolescent and young adult patients with cancer, including the ways in which cancers affecting this group differ from cancers in other age groups and what that implies about the best treatments for these cancer patients. This report identifies gaps and challenges in providing optimal care to adolescent and young adult patients with cancer and to discuss potential strategies and actions to address them. |
| cancers are hard to study because: Should I Be Tested for Cancer? H. Gilbert Welch, 2006-03-06 In this thought-provoking volume, a physician and public health expert challenges the notion that detecting cancer early always saves lives. |
| cancers are hard to study because: Preventive and Community Medicine Duncan W. Clark, 1981 |
| cancers are hard to study because: The Undying Anne Boyer, 2019-09-17 WINNER OF THE 2020 PULITZER PRIZE IN GENERAL NONFICTION The Undying is a startling, urgent intervention in our discourses about sickness and health, art and science, language and literature, and mortality and death. In dissecting what she terms 'the ideological regime of cancer,' Anne Boyer has produced a profound and unforgettable document on the experience of life itself. —Sally Rooney, author of Normal People Anne Boyer’s radically unsentimental account of cancer and the 'carcinogenosphere' obliterates cliche. By demonstrating how her utterly specific experience is also irreducibly social, she opens up new spaces for thinking and feeling together. The Undying is an outraged, beautiful, and brilliant work of embodied critique. —Ben Lerner, author of The Topeka School A week after her forty-first birthday, the acclaimed poet Anne Boyer was diagnosed with highly aggressive triple-negative breast cancer. For a single mother living paycheck to paycheck who had always been the caregiver rather than the one needing care, the catastrophic illness was both a crisis and an initiation into new ideas about mortality and the gendered politics of illness. A twenty-first-century Illness as Metaphor, as well as a harrowing memoir of survival, The Undying explores the experience of illness as mediated by digital screens, weaving in ancient Roman dream diarists, cancer hoaxers and fetishists, cancer vloggers, corporate lies, John Donne, pro-pain ”dolorists,” the ecological costs of chemotherapy, and the many little murders of capitalism. It excoriates the pharmaceutical industry and the bland hypocrisies of ”pink ribbon culture” while also diving into the long literary line of women writing about their own illnesses and ongoing deaths: Audre Lorde, Kathy Acker, Susan Sontag, and others. A genre-bending memoir in the tradition of The Argonauts, The Undying will break your heart, make you angry enough to spit, and show you contemporary America as a thing both desperately ill and occasionally, perversely glorious. Includes black-and-white illustrations |
| cancers are hard to study because: Breast Cancer in Young Women Oreste Gentilini, Ann H. Partridge, Olivia Pagani, 2020-02-07 This contributed book covers all aspects concerning the clinical scenario of breast cancer in young women, providing physicians with the latest information on the topic. Young women are a special subset of patients whose care requires dedicated expertise. The book, written and edited by internationally recognized experts who have been directly involved in the international consensus guidelines for breast cancer in young women, pays particular attention to how the disease and its planned treatment can be effectively communicated to young patients. Highly informative and carefully structured, it provides both theoretical and practice-oriented insight for practitioners and professionals involved in the different phases of treatment, from diagnosis to intervention, to follow-up – without neglecting the important role played by prevention. |
| cancers are hard to study because: Reducing Environmental Cancer Risk Suzanne H. Reuben, 2010-10 Though overall cancer incidence and mortality have continued to decline in recent years, cancer continues to devastate the lives of far too many Americans. In 2009 alone, 1.5 million American men, women, and children were diagnosed with cancer, and 562,000 died from the disease. There is a growing body of evidence linking environmental exposures to cancer. The Pres. Cancer Panel dedicated its 2008¿2009 activities to examining the impact of environmental factors on cancer risk. The Panel considered industrial, occupational, and agricultural exposures as well as exposures related to medical practice, military activities, modern lifestyles, and natural sources. This report presents the Panel¿s recommend. to mitigate or eliminate these barriers. Illus. |
| cancers are hard to study because: Cancer and Society Eric H. Bernicker, 2019-03-04 While a number of books have looked at the intersection between human health in general and other topics, such as climate change or diet, this book focuses specifically on cancer as it impacts and is impacted by social justice issues. The massive explosion of research knowledge of cancer immunology and genomics is holding out great promise of therapeutic advances, yet other human actions—climate change, pollution, business decisions, advertising – are fostering health inequalities as well as increasing risks. Those involved in cancer care and research are in a unique position to let their experiences and knowledge inform the public, yet very often have not taken strong public roles when it comes to discussing issues surrounding tobacco, climate change and health risks, financial toxicity of treatments, and diet choices. Written by a multidisciplinary team of authors and for medical oncologists, cancer researchers, occupational health workers, and related medical students, residents, and fellows, this book encourages oncologists to address public health care and the societal issues associated with cancer risk. This volume discusses the overarching theme of environmental justice and oncology, focuses on business and cancer (such as clinical trials, drug development and profits, and global disparities), as well as animals and cancer. |
| cancers are hard to study because: When Someone You Love Has Advanced Cancer: Support for Caregivers National Cancer Institute (U.S.), 2018-07-18 When Someone You Love Has Advanced Cancer is a booklet for friends and family members taking care of a person with advanced cancer. This booklet covers making new decisions about care, how to discuss issues and changes with the health care team, getting support and asking for help, life planning and advance directives, talking with family and friends, talking with children and teens about advanced cancer, communicating with your loved one who has cancer, and tips on caring for both your physical and emotional self. Related products: Caring for the Caregiver: Support for Cancer Caregivers – ePub format only – ISBN: 9780160947520 Children with Cancer: A Guide for Parents -- ePub format only -- ISBN: 9780160947537 Coping with Advanced Cancer: Support for People with Cancer -- ePub format only ISBN: 9780160947544 Eating Hints: Before, during and after Cancer Treatment -- ePub format only --ISBN: 9780160947551 Life After Cancer Treatment: Facing Forward -- ePub format only -- ISBN: 9780160947568 Pain Control: Support for People with Cancer -- ePub format only -- ISBN: 9780160947575 Radiation Therapy and You: Support for People with Cancer --ePub format only -- ISBN: 9780160947582 Surgery Choice for Women with DCIS and Breast Cancer -- ePub format only -- ISBN: 9780160947599 Taking Part in Cancer Research Studies --ePub format only -- ISBN: 9780160947605 Understanding Breast Changes: A Health Guide for Women --ePub format only -- ISBN: 9780160947612 Understanding Cervical Changes: A Health Guide for Women -- ePub format only -- ISBN: 9780160947629 When Cancer Returns: Support for People with Cancer -- ePub format only -- ISBN: 9780160947636 When Someone You Love Has Completed Cancer Treatment: Facing Forward --ePub format only -- ISBN: 9780160947650 When Someone You Love Is Being Treated for Cancer: Support for Caregivers --ePub format only -- ISBN: 9780160947667 When Your Brother or Sister Has Cancer: A Guide for Teens --ePub format only -- ISBN: 9780160947674 When Your Parent Has Cancer: A Guide for Teens -- ePub format only -- ISBN: 9780160947681 |
| cancers are hard to study because: The China Study: Revised and Expanded Edition T. Colin Campbell, Thomas M. Campbell, II, 2016-12-27 The revised and expanded edition of the bestseller that changed millions of lives The science is clear. The results are unmistakable. You can dramatically reduce your risk of cancer, heart disease, and diabetes just by changing your diet. More than 30 years ago, nutrition researcher T. Colin Campbell and his team at Cornell, in partnership with teams in China and England, embarked upon the China Study, the most comprehensive study ever undertaken of the relationship between diet and the risk of developing disease. What they found when combined with findings in Colin's laboratory, opened their eyes to the dangers of a diet high in animal protein and the unparalleled health benefits of a whole foods, plant-based diet. In 2005, Colin and his son Tom, now a physician, shared those findings with the world in The China Study, hailed as one of the most important books about diet and health ever written. Featuring brand new content, this heavily expanded edition of Colin and Tom's groundbreaking book includes the latest undeniable evidence of the power of a plant-based diet, plus updated information about the changing medical system and how patients stand to benefit from a surging interest in plant-based nutrition. The China Study—Revised and Expanded Edition presents a clear and concise message of hope as it dispels a multitude of health myths and misinformation. The basic message is clear. The key to a long, healthy life lies in three things: breakfast, lunch, and dinner. |
| cancers are hard to study because: Journal of the National Cancer Institute , 2014 |
| cancers are hard to study because: Eat to Beat Disease William W Li, 2019-03-19 Eat your way to better health with this New York Times bestseller on food's ability to help the body heal itself from cancer, dementia, and dozens of other avoidable diseases. Forget everything you think you know about your body and food, and discover the new science of how the body heals itself. Learn how to identify the strategies and dosages for using food to transform your resilience and health in Eat to Beat Disease. We have radically underestimated our body's power to transform and restore our health. Pioneering physician scientist, Dr. William Li, empowers readers by showing them the evidence behind over 200 health-boosting foods that can starve cancer, reduce your risk of dementia, and beat dozens of avoidable diseases. Eat to Beat Disease isn't about what foods to avoid, but rather is a life-changing guide to the hundreds of healing foods to add to your meals that support the body's defense systems, including: Plums Cinnamon Jasmine tea Red wine and beer Black Beans San Marzano tomatoes Olive oil Pacific oysters Cheeses like Jarlsberg, Camembert and cheddar Sourdough bread The book's plan shows you how to integrate the foods you already love into any diet or health plan to activate your body's health defense systems-Angiogenesis, Regeneration, Microbiome, DNA Protection, and Immunity-to fight cancer, diabetes, cardiovascular, neurodegenerative autoimmune diseases, and other debilitating conditions. Both informative and practical, Eat to Beat Disease explains the science of healing and prevention, the strategies for using food to actively transform health, and points the science of wellbeing and disease prevention in an exhilarating new direction. |
| cancers are hard to study because: Cancer Rehabilitation Michael O'Dell, MD, Michael Stubblefield, MD, 2009-04-22 A Doody's Core Title 2012 This new comprehensive reference provides a state-of-the-art overview of the principles of cancer care and best practices for restoring function and quality of life to cancer survivors. Authored by some of the world« leading cancer rehabilitation experts and oncology specialists, the principles section provides primer level discussions of the various cancer types and their assessment and management. The practice section thoroughly explores the identification, evaluation, and treatment of specific impairments and disabilities that result from cancer and the treatment of cancer.This groundbreaking volume enables the entire medical team to provide superior care that results in a better quality of life for cancer survivors. Features include: Multi-specialty editorship and authorship from physiatry, oncology, physical therapy, occupational therapy,and related disciplines. Focus on therapeutic management of cancer-related impairments and complications. In-depth treatment of the medical, neurologic, musculoskeletal, and general rehabilitation issues specific to this patient population. |
| cancers are hard to study because: Hard but Hopeful: the Clinical and Translational Research Progress in Pancreatic Cancer Taiping Zhang, Min Li, Bei Sun, Kuirong Jiang, 2022-11-04 |
| cancers are hard to study because: Improving the Quality of Cancer Clinical Trials Institute of Medicine, National Cancer Policy Forum, 2008-06-12 Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: (1) better inform decisions and plans of those responsible for developing new cancer therapies (2) more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic (3) be less costly than current trials The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward. |
| cancers are hard to study because: Screening Angela E. Raffle, Anne Mackie, J. A. Muir Gray, 2019-06-06 Screening programmes involve the systematic offer of testing for populations or groups of apparently healthy people to identify individuals who may be at future risk of a particular medical condition or disease, with the aim of offering intervention to reduce their risk. For many years, screening was practised without debate, and without evidence, but in the 1960s serious challenges were raised about many of the screening procedures then being practised. Benefits and harms of screening must be measured in high quality trials, and the benefits of screening must be weighed alongside the negative side-effects. Concerns were raised about potential and actual harm arising when people without a health problem received dangerous and unnecessary investigations and treatments as a result of routine screening tests. Controversy raged, and it took some 50 years to achieve widespread recognition that evidence-based and quality assured programme delivery was essential, coupled with provision of balanced informed to enable informed choice for potential participants. Commercially motivated provision of poor quality and non-evidence based screening tests is increasing and screening remains a highly contested topic that has relevance in all health systems including for the general public and media. This book serves as a practical and comprehensive guide to all aspects of screening. Following the international success of the first edition, this second edition brings extensive updates and new case study material. The first section deals with concepts, methods, and evidence, charts the story of screening back to 1861, and covers all aspects of a screening programme and how to research the full consequences. The second section is a practical guide to sound policy-making and to high quality delivery of best value screening. The controversies, paradoxes, uncertainties, and ethical dilemmas of screening are explained, and each chapter is packed with examples, real-life case histories, helpful summary points, and self-test questions. Reference is made to the NHS, a leader in screening, but the primary focus is on universal principles, making the book highly relevant across the globe. |
| cancers are hard to study because: Malignant S. Lochlann Jain, 2013-10-15 Cancer can kill: this fact makes it concrete. Still, it's a devious knave. Nearly every American will experience it up-close and all too personally, wondering why the billions of research dollars thrown at the word haven't exterminated it from the English language. Like a sapper diffusing a bomb, Jain unscrambles the emotional, bureaucratic, medical, and scientific tropes that create the thing we call cancer. Scientists debate even the most basic facts about the disease, while endlessly generated, disputed, population data produce the appearance of knowledge. Jain takes the vacuum at the center of cancer seriously and demonstrates the need to understand cancer as a set of relationships--economic, sentimental, medical, personal, ethical, institutional, statistical. Malignant analyzes the peculiar authority of the socio-sexual psychopathologies of body parts; the uneven effects of expertise and power; the potentially cancerous consequences of medical procedures such as IVF; the huge industrial investments that manifest themselves as bone-cold testing rooms; the legal mess of medical malpractice law; and the teeth-grittingly jovial efforts to smear makeup and wigs over the whole messy problem of bodies spiraling into pain and decay. Malignant examines the painful cognitive dissonances produced by the ways a culture that has relished dazzling success in every conceivable arena have twisted one of its staunchest failures into an economic triumph. The intractable foil to American achievement, cancer hands us -- on a silver platter and ready for Jain's incisively original dissection -- our sacrifice to the American Dream-- |
| cancers are hard to study because: Guiding Cancer Control National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on a National Strategy for Cancer Control in the United States, 2019-08-30 Throughout history, perhaps no other disease has generated the level of social, scientific, and political discourse or has had the degree of cultural significance as cancer. A collective in the truest sense of the word, cancer is a clustering of different diseases that afflict individuals in different ways. Its burdens are equally broad and diverse, from the physical, financial, and psychological tolls it imposes on individuals to the costs it inflicts upon the nation's clinical care and public health systems, and despite decades of concerted efforts often referred to as the war on cancer, those costs have only continued to grow over time. The causes and effects of cancer are complexâ€in part preventable and treatable, but also in part unknown, and perhaps even unknowable. Guiding Cancer Control defines the key principles, attributes, methods, and tools needed to achieve the goal of implementing an effective national cancer control plan. This report describes the current structure of cancer control from a local to global scale, identifies necessary goals for the system, and formulates the path towards integrated disease control systems and a cancer-free future. This framework is a crucial step in establishing an effective, efficient, and accountable system for controlling cancer and other diseases. |
| cancers are hard to study because: Invasion of the Prostate Snatchers Ralph Blum, Mark Scholz, 2010 Looks at the effectiveness of the prostatectomy and surveys the latest research in prostate cancer managment. |
| cancers are hard to study because: The Emperor of All Maladies Siddhartha Mukherjee, 2011-08-09 Winner of the Pulitzer Prize and a documentary from Ken Burns on PBS, this New York Times bestseller is “an extraordinary achievement” (The New Yorker)—a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence. Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years. The story of cancer is a story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception. Mukherjee recounts centuries of discoveries, setbacks, victories, and deaths, told through the eyes of his predecessors and peers, training their wits against an infinitely resourceful adversary that, just three decades ago, was thought to be easily vanquished in an all-out “war against cancer.” The book reads like a literary thriller with cancer as the protagonist. Riveting, urgent, and surprising, The Emperor of All Maladies provides a fascinating glimpse into the future of cancer treatments. It is an illuminating book that provides hope and clarity to those seeking to demystify cancer. |
| cancers are hard to study because: The Cheating Cell Athena Aktipis, 2020-03-24 A fundamental and groundbreaking reassessment of how we view and manage cancer When we think of the forces driving cancer, we don’t necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell delves into this extraordinary relationship, and shows that by understanding cancer’s evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer’s ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn’t mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease’s prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer’s fundamental nature and our relationship to it. |
| cancers are hard to study because: A New Deal for Cancer Abbe R. Gluck, Charles S Fuchs, 2021-11-16 An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future. The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success. Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients. |
| cancers are hard to study because: The Strang Cancer Prevention Center Cookbook Laura J. Pensiero, Michael P. Osborne, Susan Oliveria, 2004-04-22 A comprehensive guide to cancer prevention The oldest cancer-prevention institute in the country, New York City's famed Strang Cancer Prevention Center advocates promoting cure through early detection. It has been instrumental in developing early screening and prevention programs as well as nutrition counseling. Now readers can benefit from the same topnotch advice the center provides for its clients. A remarkable collaboration of leading cancer prevention experts and America's top gourmet chefs, The Strang Cancer Prevention Center Cookbook presents cuttingedge nutritional and scientific data on cancer, as well as a tantalizing collection of health-inducing recipes. Complete with the latest information about the crucial link between diet and health, this book introduces nature's own powerful cancer-fighting agents such as the chemicals found in many fruits and vegetables. More than 150 recipes for appetizers, soups, salads, sides, entrees, and desserts are featured. Research has shown that up to 80 percent of all cancers can be prevented by the type of changes in diet and lifestyle outlined in this book. |
| cancers are hard to study because: Cancer Sourcebook for Women, 6th Ed. James Chambers, 2018-06-01 Consumer health information about risk factors, prevention, diagnosis, and treatment of cancers of concern to women. Includes index, glossary of related terms, and other resources. |
| cancers are hard to study because: Overkill Paul A. Offit, 2020-04-14 A look at fifteen popular medical treatments that have been shown to be far more harmful than helpful, yet are still recommended by doctors. Modern medicine has made major advances in the last few decades, as more informed practices, thorough research, and incredible breakthroughs have made it possible to successfully treat and even eradicate many serious ailments. But we still rely on medical interventions that are vastly out of date and can adversely affect our health. In Overkill, Dr. Paul a Offit debunks fifteen common medical interventions that continue despite mounting evidence they are damaging or even deadly. Discussing everything from vitamins, sunscreen, and eyedrops for pinkeye to more serious procedures like heart stent placement and knee surgery, Offit—an acclaimed medical expert and patient advocate—tears down prolific medical propaganda that, for decades, has been causing more harm than good. Analyzing the history of how these practices came to be, the biology of what makes them so ineffective, and the medical culture that has consistently turned a blind eye, Overkill seeks to move the needle far away from these counterproductive treatments—and help patients advocate for their health. By educating ourselves, we can ask better questions and bring a much-needed skepticism to some of the drugs and surgeries that are too readily available—and too heavily promoted. |
| cancers are hard to study because: Reimagining Men's Cancers Michele Berman, Mark Boguski, David Tabatsky, 2016-10-04 America's fascination with celebrities never gets old. From People magazine, with a readership of 43 million to Internet sites like JustJared.com with over 80 million monthly views, celebrity information not only sells, it educates people about important issues––including cancer. Information is empowering and reading about a famous person coping with cancer can not only be inspiring, it can save a life. That's what Reimagining Cancer exemplifies through each of the books in the series Cancer doesn't have to be a death sentence. About half of all cancers are preventable and can be avoided if current medical knowledge is better delivered*. Reimagining Men's Cancers—focusing on cancers of the prostate, penis, and testicles—provides readers with that critical information to help them manage, cope, and recover through a concise, easy-to-read style and format. Beginning with a view of basic anatomy and an overview of how we view a particular cancer today, chapters flow easily into an explanation of signs, symptoms, diagnosis, scientific information and guidelines, and include a comprehensive survey of treatments and prevention. Woven throughout are stories, both medical and anecdotal, from men such as Joe Torre, Robert De Niro, Sir Ian McKellen, and Scott Hamilton. Education is the key, and by using celebrity stories, Reimagining Men's Cancers can attract countless readers who might otherwise not pay attention to an epidemic that is likely to affect them or a loved one. * The recent World Cancer Report from the World Health Organization |
| cancers are hard to study because: Assessment of Technologies for Determining Cancer Risks from the Environment , 1981 |
| cancers are hard to study because: Dr. Patrick Walsh's Guide to Surviving Prostate Cancer Patrick C. Walsh, Janet Farrar Worthington, 2013-01-29 This guide covers every aspect of prostate cancer, from potential causes including diet to tests for diagnosis, curative treatment, and innovative means of controlling advanced stages of cancer. |
| cancers are hard to study because: Health Risks from Exposure to Low Levels of Ionizing Radiation Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council, 2006-03-23 This book is the seventh in a series of titles from the National Research Council that addresses the effects of exposure to low dose LET (Linear Energy Transfer) ionizing radiation and human health. Updating information previously presented in the 1990 publication, Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V, this book draws upon new data in both epidemiologic and experimental research. Ionizing radiation arises from both natural and man-made sources and at very high doses can produce damaging effects in human tissue that can be evident within days after exposure. However, it is the low-dose exposures that are the focus of this book. So-called “late” effects, such as cancer, are produced many years after the initial exposure. This book is among the first of its kind to include detailed risk estimates for cancer incidence in addition to cancer mortality. BEIR VII offers a full review of the available biological, biophysical, and epidemiological literature since the last BEIR report on the subject and develops the most up-to-date and comprehensive risk estimates for cancer and other health effects from exposure to low-level ionizing radiation. |
| cancers are hard to study because: Psychosocial Stress and Cancer Cary L. Cooper, 1984 Psychosocial Stress and Cancer Edited by Cary L. Cooper University of Manchester Institute of Science and Technology The importance of stress in the development of heart disease is well established, but its role in cancer is only just beginning to be investigated. Recent research in humans indicates that various life events, personality pre-dispositions, as well as immunological and central nervous system interactions, may trigger the cancer process, or at the very least accentuate its development. In this book, a number of recognized international authorities provide state-of-the-art statements on the key issues of the subject. Beginning with a review of the findings to date, there follows more in-depth analysis of potential social/psychological precursors to cancer, and the way in which they may influence the aetiology and development of the disease. The final section deals with the way in which psychosocial factors may be managed in cancer patients, and provides a comparative summary of the various methodological approaches utilized in studies exploring the field of psychological oncology. The book will provide a unique digest of current knowledge as well as a starting point for future research, and will be invaluable to all concerned with the study and management of the cancer process. Other Wiley titles on this subject include: Stress Research: Issues for the Eighties Edited by Cary L. Cooper 160 pages February 1983 Mind and Cancer Prognosis Basil A. Stoll, St Thomas’s Hospital and Royal Free Hospital, London 214 pages December 1979 All about Cancer Chris Williams, CRC Medical Oncology Unit, University of Southampton 404 pages April 1983 |
| cancers are hard to study because: Journal National Cancer Institute (U.S.), 1975 |
| cancers are hard to study because: The Biological Basis of Cancer Robert G. McKinnell, 2006-08-28 This is a revised and updated edition of a text used in undergraduate courses on cancer biology. It covers everything from the molecular basis of cancer to clinical aspects of the subject, and has a lengthy bibliography designed to assist newcomers with the cancer literature. An introduction acquaints students with the biological principles of cancer and the human dimensions of the disease by considering genuine cases of cancer in fictionalized letters. Other chapters discuss cancer pathology, metastasis, carcinogenesis, genetics, oncogenes and tumor suppressors, epidemiology, and the biological basis of cancer treatment. Also included are an appendix with descriptions of common forms of cancer, a glossary of cancer-related terms and colour plates to illustrate the pathology of many of the types of cancer discussed in the text. Upper-division undergraduates with a background in freshman biology and chemistry, as well as beginning graduate students will find this a valuable text. |
Cancer - World Health Organization (WHO)
Feb 3, 2025 · The most common cancers are breast, lung, colon and rectum and prostate cancers. Around one-third of deaths from cancer are due to …
Cancer - World Health Organization (WHO)
Feb 3, 2022 · Les cancers les plus courants sont le cancer du sein, le cancer du poumon, le cancer colorectal et le cancer de la prostate. Près d’un …
Cancer - World Health Organization (WHO)
Jun 5, 2025 · Survivorship care includes a detailed plan for monitoring cancer recurrence and detection of new cancers, assessing and managing …
Colorectal cancer - World Health Organization (WHO)
Jul 11, 2023 · Incidence rates of colorectal cancer have been decreasing in high-income countries, largely as a result of effective screening …
Cancer - World Health Organization (WHO)
Les cancers du poumon, de la prostate, colorectal, de l'estomac et du foie sont les types de cancer les plus courants chez les hommes, tandis que les …
Cancer - World Health Organization (WHO)
Feb 3, 2025 · The most common cancers are breast, lung, colon and rectum and prostate cancers. Around one-third of deaths from cancer are due to tobacco use, high body mass index, alcohol …
Cancer - World Health Organization (WHO)
Feb 3, 2022 · Les cancers les plus courants sont le cancer du sein, le cancer du poumon, le cancer colorectal et le cancer de la prostate. Près d’un tiers des décès par cancer sont dus au …
Cancer - World Health Organization (WHO)
Jun 5, 2025 · Survivorship care includes a detailed plan for monitoring cancer recurrence and detection of new cancers, assessing and managing long-term effects associated with cancer …
Colorectal cancer - World Health Organization (WHO)
Jul 11, 2023 · Incidence rates of colorectal cancer have been decreasing in high-income countries, largely as a result of effective screening programmes. The prognosis for colorectal cancer varies …
Cancer - World Health Organization (WHO)
Les cancers du poumon, de la prostate, colorectal, de l'estomac et du foie sont les types de cancer les plus courants chez les hommes, tandis que les femmes sont le plus souvent atteintes des …
Cancer - World Health Organization (WHO)
Feb 2, 2022 · Yet, many of these deaths can be avoided. Between 30-50% of cancers are preventable by healthy lifestyle choices such as avoidance of tobacco and public health …
Childhood cancer - World Health Organization (WHO)
Feb 4, 2025 · Genetic causes of childhood cancers are relevant in only a small proportion children with cancer. There is no high-quality evidence to support population-based screening …
Cervical cancer - World Health Organization (WHO)
Mar 5, 2024 · As of 2023, there are 6 HPV vaccines available globally. All protect against the high-risk HPV types 16 and 18, which cause most cervical cancers and have been shown to be safe …
Human papillomavirus and cancer - World Health Organization …
Mar 5, 2024 · Cervical cancers account for over 90% of HPV-related cancers in women (1). The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries. …
Global cancer burden growing, amidst mounting need for services
Feb 1, 2024 · Ahead of World Cancer Day, the World Health Organization (WHO)’s cancer agency, the International Agency for Research on Cancer (IARC), released the latest estimates of the …
